Simcere Pharmaceutical Group Limited's receivables is $2.5B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Simcere Pharmaceutical Group Limited (2096.HK) currently reports a receivables of $2.5B as of June 2026. That compares with $2.6B in the prior-year period — down 4.3% year over year. Use the charts on this page to explore Simcere Pharmaceutical Group Limited's receivables history and peer comparisons.
Simcere Pharmaceutical Group Limited's receivables decreased from $2.6B to $2.5B — a 4.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Simcere Pharmaceutical Group Limited reported $2.5B in receivables as of June 2026. That compares with $2.6B in the prior-year period — down 4.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $2.5B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Simcere Pharmaceutical Group Limited, and consider following 2096.HK for alerts when major investors trade the stock.